Cargando…

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

BACKGROUND: Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-resistance, associated risk factors, and the association of mono-resistance on treatment outcomes. METHODS: A prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villegas, Leonela, Otero, Larissa, Sterling, Timothy R., Huaman, Moises A., Van der Stuyft, Patrick, Gotuzzo, Eduardo, Seas, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821555/ https://www.ncbi.nlm.nih.gov/pubmed/27045684 http://dx.doi.org/10.1371/journal.pone.0152933

Ejemplares similares

A prospective longitudinal study of tuberculosis among household contacts of smear-positive tuberculosis cases in Lima, Peru
por: Otero, Larissa, et al.
Publicado: (2016)

HIV screening among newly diagnosed TB patients: a cross sectional study in Lima, Peru
por: Ramírez, Suzanne, et al.
Publicado: (2018)

Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru
por: Lackey, Brian, et al.
Publicado: (2015)

A Diagnostic Accuracy Study of Xpert®MTB/RIF in HIV-Positive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru
por: Carriquiry, Gabriela, et al.
Publicado: (2012)

Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
por: Otero, L., et al.
Publicado: (2023)

Health literacy and knowledge related to tuberculosis among outpatients at a referral hospital in Lima, Peru
por: Penaloza, Rosalina, et al.
Publicado: (2019)

Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru
por: Shah, Lena, et al.
Publicado: (2015)

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
por: Schwalb, Alvaro, et al.
Publicado: (2021)

Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics
por: Zegarra-Chapoñan, Roberto, et al.
Publicado: (2021)

Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru
por: Huaman, Moises A., et al.
Publicado: (2018)

Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-eastern part of Lima, Peru
por: Barletta, Francesca, et al.
Publicado: (2013)

High Prevalence of Primary Multidrug Resistant Tuberculosis in Persons with No Known Risk Factors
por: Otero, Larissa, et al.
Publicado: (2011)

Long-term impact on cardiopulmonary function and quality of life among patients recovered from SARS-CoV-2 infection in a 6-month follow-up period in Lima, Peru: FUNCTION cohort study protocol
por: Cachay, Rodrigo, et al.
Publicado: (2023)

Public Transportation and Pulmonary Tuberculosis, Lima, Peru
por: Horna-Campos, Olivia J., et al.
Publicado: (2007)

Spatial scale of tuberculosis transmission in Lima, Peru
por: Huang, Chuan-Chin, et al.
Publicado: (2022)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Clinical situation of Venezuelan migrants living with HIV in a hospital in Lima, Peru
por: Huerta-Vera, Genesis S, et al.
Publicado: (2021)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
por: Aruldhas, Blessed Winston, et al.
Publicado: (2019)

Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012)

Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)

Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
por: Cohen, Ted, et al.
Publicado: (2011)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2016)

1381. Barriers and Facilitators to Prompt Diagnosis of Tuberculosis in Lima, Peru
por: Geadas, Carolina, et al.
Publicado: (2023)

Missed opportunities for HIV control: Gaps in HIV testing for partners of people living with HIV in Lima, Peru
por: Vasquez, Ana L., et al.
Publicado: (2017)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2019)

Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima—Peru
por: Lopez, Kattya, et al.
Publicado: (2021)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
por: Cornejo Garcia, Jose Gabriel, et al.
Publicado: (2018)

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

Socioeconomic and Behavioral Factors Associated with Tuberculosis Diagnostic Delay in Lima, Peru
por: Bonadonna, Lily V., et al.
Publicado: (2018)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Rifampicin Mono-Resistant Tuberculosis—A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control
por: Malenfant, Jason H, et al.
Publicado: (2021)

Knowledge, attitudes and practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Lima, Peru
por: García, Coralith, et al.
Publicado: (2011)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru.
por: Willingham, F F, et al.
Publicado: (2001)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis
por: Cilfone, NA, et al.
Publicado: (2015)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
por: Sahebi, Leyla, et al.
Publicado: (2016)

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
por: Munir, Asma, et al.
Publicado: (2019)

Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid
por: Tang, Peijun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8nadogbrp2fk3a02jfsdem01im